EFTA01520926.pdf

GHISLAINE MAXWELL For the Period 12/1111 to 12/31/11 Equity Summary Beginning Ending Change Current Asset Categories Asset Categories Markel Value Market Value In Value Allocation US Large Cap Equity 283,435.07 226,931.66 (56,503.41) 5% US Small!Mid Cap Equity 5,010.00 4,440.00 (570.00) 1% Non-US Equity Non-US Equity 501,612.46 431,810.63 (69,801.83) 9% Preferred Stocks 404,636.00 409,576.00 4,940.00 8% US Srnall.APO Cap &MIX Concentrated 8 Other Equity 192,845.50 193,953.50 1,108.00 4% Unca ssified 158,826.30 148,188.75 (10,637.55) 3% Um:ass/turd Total Value $1,546,365.33 $1,414,900.54 ($131,464.79) 30% Prelarred Stock, ccocnu sda Mir Current Market Value/Cost Period Value Market Value 1,414.900.54 Lara•cia Sawa Tax Cost 1,772,327.38 Unrealized Gain/Loss (397.788.37) Equity as a percentage of your portfolio - 30 % Estimated Annual Income 50,711.46 Accrued Dividends 6,418.96 Yield 3.57% Note: ^ Unrealized Gain/Loss is shown as "N/A- in cases where we do not have appropriate cost information for all tax lots comprising the position. Please contact your J.P. Morgan team for additional information. Equity Detail J.P. Morgan Page 4 of 77 Confidential Treatment Requested by JPMorgan JPM-SDNY-00048273 Chase CONFIDENTIAL SDNY_GM_00317471 EFTA01520926